Trial intelligence / Profile preview

Quetiapine Brain Imaging in Anxious Depression

NCT00982345Phase 4Completed

Sponsor
Indiana University School of Medicine
Start
Mar 2009
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of quetiapine in major depressive disorder (MDD), sponsored by Indiana University School of Medicine. Started Mar 2009; status: completed.

02

Drugs

quetiapine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00982345.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00982345.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call